FR2706307A1 - Formula for the treatment of AIDS - Google Patents

Formula for the treatment of AIDS Download PDF

Info

Publication number
FR2706307A1
FR2706307A1 FR9307669A FR9307669A FR2706307A1 FR 2706307 A1 FR2706307 A1 FR 2706307A1 FR 9307669 A FR9307669 A FR 9307669A FR 9307669 A FR9307669 A FR 9307669A FR 2706307 A1 FR2706307 A1 FR 2706307A1
Authority
FR
France
Prior art keywords
formulation according
aids
essential oils
mother
dyes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9307669A
Other languages
French (fr)
Other versions
FR2706307B1 (en
Inventor
Pelletier Jacques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9307669A priority Critical patent/FR2706307B1/en
Publication of FR2706307A1 publication Critical patent/FR2706307A1/en
Application granted granted Critical
Publication of FR2706307B1 publication Critical patent/FR2706307B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Abstract

The invention relates to a formula for treating AIDS. It consists of an antiviral mixture of essential oils, an antibiotic, mother tinctures, herbal medicines and trace elements. The synergy produced by this formula is likely to bring about a remission or even a cure of AIDS.

Description

LA PRESENTE INVENTION CONCERNE LA DECOUVERTE D'UNE FORMULE POUR TRAITER
LE SIDA.THIS INVENTION CONCERNS THE DISCOVERY OF A TREATMENT FORMULA
AIDS.

LE SYNDROME D'IMMUNODEFICIENCE ACQUISE EST UNE INFECTION VIRALE DONT LE
DEVELOPPEMENT DEVIENT CONSIDERABLE EN EUROPE ET NOTAMMENT EN FRANCE, AUX
ETATS-UNIS, EN AFRIQUE, DANS LES PAYS DE "L'EX-UNION SOVIETIQUE". THE ACQUIRED IMMUNODEFICIENCY SYNDROME IS A VIRAL INFECTION OF WHICH
DEVELOPMENT BECOMES CONSIDERABLE IN EUROPE AND ESPECIALLY IN FRANCE,
UNITED STATES, AFRICA, IN THE COUNTRIES OF "THE SOVIET EX-UNION".

CERTAINES ESTIMATIONS RECENTES PORTENT A CROIRE QUE DIX MILLIONS D'INDI
VIDUS ONT ETE EXPOSES AU VIRUS DU SIDA. LES INDIVIDUS AFFECTES PRESENTENT
UNE IMMUNODEPRESSION IMPORTANTE ET LrISSUE DE LEUR MALADIE EST MALHEUREU
SEMENT FATALE, A L'HEURE ACTUELLE.SOME RECENT ESTIMATES ARE BELIEVE THAT TEN MILLION INDI
VIDUS HAVE BEEN EXPOSED TO THE AIDS VIRUS. AFFECTED INDIVIDUALS PRESENT
IMPORTANT AND LARGE IMMUNODEPRESSION OF THEIR DISEASE IS UNHAPPY
SAT FATAL, AT CURRENT TIME.

LA TRANSMISSION DE LA MALADIE PEUT S'EFFECTUER DE TROIS FACONS DIFFEREN
TES:
- PAR CONTACT SEXUEL, C'EST LA RAISON POUR LAQUELLE ON DIT QUE LE
SIDA EST UNE MALADIE SEXUELLEMENT TRANSMISSIBLE.THERE ARE THREE DIFFERENT WAYS TO TRANSMIT THE DISEASE
YOUR:
- BY SEXUAL CONTACT, THIS IS THE REASON FOR WHICH IT IS SAID THAT THE
AIDS IS A SEXUALLY TRANSMITTED DISEASE.

- PAR VOIE INTRAVEINEUSE POUR LES TOXICOMANES. - BY intravenous route for drug addicts.

- UN GRAND NOMBRE DE MALADES ONT ETE INFECTES APRES AVOIR RECU UNE
TRANSFUSION DE SANG CONTAMINE.- A LARGE NUMBER OF SICK PERSONS WERE INFECTED AFTER RECEIVING A
TRANSFUSION OF CONTAMINATED BLOOD.

L'AGENT MIS EN CAUSE EST UN VIRUS OU, SANS DOUTE, PLUSIEURS VIRUS, DONT
CERTAINS SONT DES MUTANTS.THE AGENT INVOLVED IS A VIRUS OR, WITHOUT DOUBT, SEVERAL VIRUSES, INCLUDING
SOME ARE MUTANTS.

LES VIRUS HIV1 ET HIV2 SONT RECONNUS COMME AGENTS RESPONSABLES DU SIDA,
ILS APPARTIENNENT A UN MEME GROUPE ET ONT UN MEME TYPE D'ORGANISATION
GENOMIQUE.THE HIV1 AND HIV2 VIRUSES ARE RECOGNIZED AS AGENTS RESPONSIBLE FOR AIDS,
THEY BELONG TO THE SAME GROUP AND HAVE THE SAME TYPE OF ORGANIZATION
GENOMICS.

LE NOMBRE CROISSANT DE MALADES CONTAMINES IMPOSE, DES MAINTENANT, DE MET
TRE A LA DISPOSITION D'UN LABORATOIRE DE FABRICATION UNE FORMULE ANTIVI
RALE A BASE DE PRODUITS NATURELS, SANS RISQUE D'EFFETS IATROGENES.THE GROWING NUMBER OF CONTAMINATED DISEASES NOW IMPOSES MET
TRE AN ANTIVI FORMULA AVAILABLE TO A MANUFACTURING LABORATORY
RALE BASED ON NATURAL PRODUCTS, WITHOUT RISK OF IATROGENIC EFFECTS.

CETTE FORMULE CONCUE PRINCIPALEMENT A BASE D'HUILES ESSENTIELLES DONT CHA
CUNE A SES VERTUS PHARMACODYNAMIQUES PROPRES, MAIS DONT LE MELANGE PRESEN
TE UNE SYNERGIE PERMETTANT UNE REPONSE CONTRE L'INFECTION PAR LE HIV.THIS FORMULA DESIGNED MAINLY BASED ON ESSENTIAL OILS OF WHICH CHA
CUNE HAS ITS OWN PHARMACODYNAMIC VERSUS, BUT OF WHICH THE MIXTURE PRESENTED
TE A SYNERGY ALLOWING A RESPONSE AGAINST HIV INFECTION.

LA PRESENTE INVENTION VISE, AINSI, A FOURNIR DES MOYENS NON ENCORE UTILI
SES A CE JOUR, MAIS OFFRANT TOUTES LES QUALITES D'UN ADJUVANT DE CHOIX
DANS LA LUTTE CONTRE LE SIDA.THE PRESENT INVENTION THUS AIMS AT PROVIDING MEANS NOT YET USED
SES TO DATE, BUT OFFERING ALL THE QUALITIES OF A CHOICE ADJUVANT
IN THE FIGHT AGAINST AIDS.

L'INVENTION SE RESUME, DE FACON GENERALE, EN UN MELANGE D'HUILES ESSENTIEL
LES COMPRENANT ENTRE 1,02% ET 4,08% DE CHACUN DES COMPOSANTS SUIVANTS:
OCYMUM BASILICUM, APIOL, ORIGANUM VULGARE, THYMUS VULGARIS, SATUREIA HOR
TENSIS OU SATUREIA MONTANA, SANTALUM ALBUM, THUYA OCCIDENTALIS, ANDROPOGON
CITRATUS, EUGENIA CARYOPHYLATA, CITRUS LIMONUM, CEDRUS ATLANTICA, ALLIUM
CEPA, ROSMARINUS OFFICINALIS, PINUS SIBERIA, MATRICARIA CHAMOMILLA, JUNI
PERUS COMMUNIS, EUCALYPTUS GLOBULUS, MENTHA PIPERITA, MELALEUCA LEUCADEN
DRON,CORIANDRUM SATIVUM, VERBENA TRIPHYLLA, MELISSA OFFICINALIS, CITRUS
AURANTIUM,HUMULUS LUPULUS.THE INVENTION CAN BE SUMMARIZED, IN GENERAL, IN AN ESSENTIAL OIL MIXTURE
INCLUDING BETWEEN 1.02% AND 4.08% OF EACH OF THE FOLLOWING COMPONENTS:
OCYMUM BASILICUM, APIOL, ORIGANUM VULGARE, THYMUS VULGARIS, SATUREIA HOR
TENSIS OR SATUREIA MONTANA, SANTALUM ALBUM, THUYA OCCIDENTALIS, ANDROPOGON
CITRATUS, EUGENIA CARYOPHYLATA, CITRUS LIMONUM, CEDRUS ATLANTICA, ALLIUM
CEPA, ROSMARINUS OFFICINALIS, PINUS SIBERIA, MATRICARIA CHAMOMILLA, JUNI
PERUS COMMUNIS, EUCALYPTUS GLOBULUS, MENTHA PIPERITA, MELALEUCA LEUCADEN
DRON, CORIANDRUM SATIVUM, VERBENA TRIPHYLLA, MELISSA OFFICINALIS, CITRUS
AURANTIUM, HUMULUS LUPULUS.

EN D'AUTRES TERMES, L'INVENTION A POUR OBJET UN MELANGE D'HUILES ESSENTIEL
LES PRODUISANT LES EFFETS D'UN ANTIVIRAL PUISSANT, EN PREMIER LIEU.IN OTHER TERMS, THE INVENTION SUBJECT TO A MIXTURE OF ESSENTIAL OILS
PRODUCING THE EFFECTS OF A POWERFUL ANTIVIRAL, FIRST.

LA PRESENTE INVENTION FAIT INTERVENIR EGALEMENT UN ANTIBIOTIQUE D'ORIGINE
VEGETALE: L'ALLICINE, AINSI QUE DES TEINTURES MERES D'ARSENICUM ALBUM ET
DE CENTELLA ASIATICA; DE MEME QUE L'UTILISATION TOTALE DE PLANTES EN PHY
TOTHERAPIE: LE ROSEAU ODORANT, LA MONARDE, LES BOURGEONS DE SAPIN.THIS INVENTION ALSO INVOLVES AN ORIGINAL ANTIBIOTIC
VEGETABLE: ALLICIN, AS WELL AS MOTHER DYES OF ARSENICUM ALBUM AND
DE CENTELLA ASIATICA; AS IS THE TOTAL USE OF PHY PLANTS
TOTHERAPY: THE SMELLING ROSEAU, THE MONARDE, THE FIR TREES.

ENFIN L'INVENTION INTRODUIT DES OLIGO-ELEMENTS: CUIVRE, ARGENT, OR, MAGNE
SIUM ET GERMANIUM.FINALLY THE INVENTION INTRODUCED TRACE ELEMENTS: COPPER, SILVER, GOLD, MAGNE
SIUM AND GERMANIUM.

LA PRESENTE INVENTION REUNIT DONC UN MELANGE ANTIVIRAL COMPOSE D'HUILES
ESSENTIELLES, DONT LA SYNERGIE EST HAUTEMENT PERFORMANTE, ASSOCIE A UN AN
TIBIOTIQUE, DES TEINTURES MERES, AINSI QUE DE LA PHYTOTHERAPIE ET EGALE
MENT DES OLIGO-ELEMENTS NECESSAIRES DONT LA PLUPART D'ORIGINE METALLIQUE,
CERTAINS FORMANT UN CATALYSEUR DE LA DIATHESE IV OU ANERGIQUE (MENETRIER).THIS INVENTION COMES TOGETHER AN ANTIVIRAL MIXTURE OF OILS
ESSENTIAL, OF WHICH THE SYNERGY IS HIGHLY PERFORMING, ASSOCIATED WITH A YEAR
TIBIOTIC, MOTHER DYES, AS WELL AS PHYTOTHERAPY AND EQUAL
LENT NECESSARY TRACE ELEMENTS OF WHICH MOST METALLIC ORIGIN,
SOME FORMING A DIATHESIS IV OR ANERGIC (MENETRIER) CATALYST.

LA PRESENTE INVENTION EST UN ADJUVANT DE TRES HAUTE QUALITE DANS LE TRAI
TEMENT DU SIDA. THIS INVENTION IS A VERY HIGH QUALITY ADJUVANT IN TRAI
TENT OF AIDS.

Claims (6)

REVENDICATIONS 1) LA FORMULATION CONTRE LE SIDA EST CARACTERISEE EN CE QU'ELLE CONTIENT:1) THE FORMULATION AGAINST AIDS IS CHARACTERIZED IN THAT IT CONTAINS: A - UN MELANGE D'HUILES ESSENTIELLES, A - A MIXTURE OF ESSENTIAL OILS, B - UN ANTIBIOTIQUE, B - AN ANTIBIOTIC, C - DES TEINTURES MERES, C - MOTHER DYES, D - DE LA PHYTOTHERAPIE, D - PHYTOTHERAPY, E - DES OLIGO-ELEMENTS, E - OLIGO-ELEMENTS, 2) FORMULATION SELON LA REVENDICATION 1(A) CARACTERISEE EN CE QUE LE ME2) FORMULATION ACCORDING TO CLAIM 1 (A) CHARACTERIZED IN THAT ME LANGE D'HUILES ESSENTIELLES COMPREND ENTRE 1,02% ET 4,08% DE CHACUN LANGE OF ESSENTIAL OILS INCLUDES BETWEEN 1.02% AND 4.08% EACH DES COMPOSANTS SUIVANTS: OCYMUM BASILICUM, APIOL, ORIGANUM VULGARE, OF THE FOLLOWING COMPONENTS: OCYMUM BASILICUM, APIOL, ORIGANUM VULGARE, THYMUS VULGARIS, SATUREIA HORTENSIS OU SATUREIA MONTANA, SANTALUM THYMUS VULGARIS, SATUREIA HORTENSIS OR SATUREIA MONTANA, SANTALUM ALBUM, THUYA OCCIDENTALIS, ANDROPOGON CITRATUS,EUGENIA CARYOPHYLATA, ALBUM, THUYA OCCIDENTALIS, ANDROPOGON CITRATUS, EUGENIA CARYOPHYLATA, CITRUS LIMONUM, CEDRUS ATLANTICA, ALLIUM CEPA, ROSMARINUS OFFICINALIS, CITRUS LIMONUM, CEDRUS ATLANTICA, ALLIUM CEPA, ROSMARINUS OFFICINALIS, PINUS SIBERIA, MATRICARIA CHAMOMILLA, JUNIPERUS COMMUNIS, EUCALYPTUS PINUS SIBERIA, MATRICARIA CHAMOMILLA, JUNIPERUS COMMUNIS, EUCALYPTUS GLOBULUS, MENTHA PIPERITA, MELALEUCA LEUCADENDRON,CORIANDRUM SATIVUM, GLOBULUS, MENTHA PIPERITA, MELALEUCA LEUCADENDRON, CORIANDRUM SATIVUM, VERBENA TRIPHYLLA, MELISSA OFFICINALIS, CITRUS AURANTIUM, HUMULUS LU VERBENA TRIPHYLLA, MELISSA OFFICINALIS, CITRUS AURANTIUM, HUMULUS LU PULUS. PULUS. 3) FORMULATION SELON LA REVENDICATION 1(B) CARACTERISEE EN CE QUE L'AN3) FORMULATION ACCORDING TO CLAIM 1 (B) CHARACTERIZED IN THAT THE YEAR TIBIOTIQUE D'ORIGINE VEGETALE EST L'ALLICINE. TIBIOTIC OF PLANT ORIGIN IS ALLICIN. 4) FORMULATION SELON LA REVENDICATION 1(C) CARACTERISEE EN CE QUE LES4) FORMULATION ACCORDING TO CLAIM 1 (C) CHARACTERIZED IN THAT THE TEINTURES MERES SONT DES TEINTURES MERES D'ARSENICUM ALBUM ET DE CEN MOTHER DYES ARE MOTHER DYES OF ARSENICUM ALBUM AND CEN TELLA ASIATICA. TELLA ASIATICA. 5) FORMULATION SELON LA REVENDICATION 1(D) CARACTERISEE EN CE QUE LES5) FORMULATION ACCORDING TO CLAIM 1 (D) CHARACTERIZED IN THAT THE PLANTES TOTALES PHYTOTHERAPEUTIQUES SONT LE ROSEAU ODORANT, LA MONAR TOTAL PHYTOTHERAPEUTIC PLANTS ARE THE SMELLING ROSE, MONAR DE ET LES BOURGEONS DE SAPIN. OF AND THE TREES OF FIR. 6) FORMULATION SELON LA REVENDICATION 1(E) CARACTERISEE EN CE QUE LES6) FORMULATION ACCORDING TO CLAIM 1 (E) CHARACTERIZED IN THAT THE OLIGO-ELEMENTS SONT LE CUIVRE, L'ARGENT, L'OR, LE MAGNESIUM, LE GER OLIGO-ELEMENTS ARE COPPER, MONEY, GOLD, MAGNESIUM, GER MANIUM.  MANIUM.
FR9307669A 1993-06-18 1993-06-18 Formula for treatment of AIDS. Expired - Fee Related FR2706307B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9307669A FR2706307B1 (en) 1993-06-18 1993-06-18 Formula for treatment of AIDS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9307669A FR2706307B1 (en) 1993-06-18 1993-06-18 Formula for treatment of AIDS.

Publications (2)

Publication Number Publication Date
FR2706307A1 true FR2706307A1 (en) 1994-12-23
FR2706307B1 FR2706307B1 (en) 1995-12-01

Family

ID=9448494

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9307669A Expired - Fee Related FR2706307B1 (en) 1993-06-18 1993-06-18 Formula for treatment of AIDS.

Country Status (1)

Country Link
FR (1) FR2706307B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024437A1 (en) * 2001-09-21 2003-03-27 Stone Island Holdings Ltd Allicin
FR2829930A1 (en) * 2001-09-27 2003-03-28 Gattefosse Holding Cosmetic composition comprising essential oils rich in carvacrol, eugenol and thymol for use in protecting the skin against oxidative stress and the effects of free radicals

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563109A1 (en) * 1984-04-18 1985-10-25 Truc Daniel Phytotherapeutic composition composed of plants containing oils, plants containing mineral salts, plants containing waxes, oxidases and mineral salts, which treats diseases of the airways, and process for preparing it
DE3801900A1 (en) * 1988-01-23 1989-09-07 Nink Karl Heinz Use of terpene-containing essential oils for controlling Aids and Arc, and pharmaceutical compositions containing them
SU1572637A1 (en) * 1987-06-17 1990-06-23 Научно-Исследовательский Институт Туберкулеза Им.Ш.А.Алимова Medicinal agent for prevention side effect of antituberculous preparations
GB2238476A (en) * 1989-11-04 1991-06-05 K T Lalvani Therapeutic aquatic animal and garlic products
DE4024155A1 (en) * 1990-07-30 1992-02-06 Marcela Dipl Ing Holzhey Internal use of allicin-urotropin product - to treat bacterial, viral and fungal infections including meningitis, rabies, AIDs, tuberculosis, leprosy, plague and cancer
JPH04149135A (en) * 1990-10-09 1992-05-22 Kureha Chem Ind Co Ltd Perfume composition and perfume product therefrom

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563109A1 (en) * 1984-04-18 1985-10-25 Truc Daniel Phytotherapeutic composition composed of plants containing oils, plants containing mineral salts, plants containing waxes, oxidases and mineral salts, which treats diseases of the airways, and process for preparing it
SU1572637A1 (en) * 1987-06-17 1990-06-23 Научно-Исследовательский Институт Туберкулеза Им.Ш.А.Алимова Medicinal agent for prevention side effect of antituberculous preparations
DE3801900A1 (en) * 1988-01-23 1989-09-07 Nink Karl Heinz Use of terpene-containing essential oils for controlling Aids and Arc, and pharmaceutical compositions containing them
GB2238476A (en) * 1989-11-04 1991-06-05 K T Lalvani Therapeutic aquatic animal and garlic products
DE4024155A1 (en) * 1990-07-30 1992-02-06 Marcela Dipl Ing Holzhey Internal use of allicin-urotropin product - to treat bacterial, viral and fungal infections including meningitis, rabies, AIDs, tuberculosis, leprosy, plague and cancer
JPH04149135A (en) * 1990-10-09 1992-05-22 Kureha Chem Ind Co Ltd Perfume composition and perfume product therefrom

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CD-ROM VIDAL, O.V.P. - EDITIONS DU VIDAL, 1992, PARIS *
DATABASE WPI Section Ch Week 9107, Derwent World Patents Index; Class B04, AN 91-050090 *
DATABASE WPI Section Ch Week 9227, Derwent World Patents Index; Class B04, AN 92-223430 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024437A1 (en) * 2001-09-21 2003-03-27 Stone Island Holdings Ltd Allicin
EA009169B1 (en) * 2001-09-21 2007-10-26 Стоун Айлэнд Холдингз Лтд. Preparation containing allicin for the treatment of multiply drug resistant bacteria
EA013519B1 (en) * 2001-09-21 2010-06-30 Стоун Айлэнд Холдингз Лтд. Antibacterial or pediculicidal preparation comprising allicin
FR2829930A1 (en) * 2001-09-27 2003-03-28 Gattefosse Holding Cosmetic composition comprising essential oils rich in carvacrol, eugenol and thymol for use in protecting the skin against oxidative stress and the effects of free radicals

Also Published As

Publication number Publication date
FR2706307B1 (en) 1995-12-01

Similar Documents

Publication Publication Date Title
Haudecoeur et al. Traditional uses, phytochemistry and pharmacological properties of African Nauclea species: A review
Ramdane et al. Ethnobotanical study of some medicinal plants from Hoggar, Algeria
Libman et al. Medicinal plants: an important asset to health care in a region of Central Laos
Costa‐Neto Implications and applications of folk zootherapy in the state of Bahia, Northeastern Brazil
Gupta et al. Apitherapy: holistic healing through the honeybee and bee products in countries with poor healthcare system
Nikolaou et al. Accidental poisoning after ingestion of “aphrodisiac” berries: diagnosis by analytical toxicology
FR2830198A1 (en) Compositions containing Ravensara aromatica essential oil and one or more other essential oils for treatment of viral, fungal, and parasitic infections, cystic fibrosis, AIDS, and certain tumors
FR2706307A1 (en) Formula for the treatment of AIDS
Ragazzi Amber, a stone of sun for ancient medicines
Mahboubi et al. Squill (Drimia maritima L.) and its novel biological activity
Obika et al. Essay on Igbo Folk Medicine as an Indispensable aspect of Health Care delivery in the 21 st Century
WO2002062364A1 (en) Antiviral composition made from medicinal plants for combating hiv/aids
BE1020027A3 (en) HOMEOPATHIC COMPOSITIONS FOR THE TREATMENT OF BACK PAIN AND SCIATICS.
Goje et al. The Anti Snake Venom Effects of the Aqueous Extracts of Boswellia delzielli Stem Bark on the Parameters of Hepatic Functions and Energy Metabolism of Naja nigricollis (Spitting Cobra) Envenomed Albino Rats
Wadnerwar Preclinical Evaluation of Antidotal Property of Mritasanjeevana agada in Poisoning-A Study Protocol
FR3080282A1 (en) PHYTOMEDICAMENT WITH ANTIBACTERIAL ACTIVITY AGAINST GASTRODUODENAL ULCER AND CROHN'S DISEASE
Seleteng-Kose Commercial traditional herbal mixtures sold in the Maseru District of Lesotho
WO2007137389A1 (en) Use of compounds obtained from the neem tree (azadirachta indica) for the treatment of hiv/aids
Tamuno-Opubo et al. Effect of Ethanoic Extract of Treculia Africana Seeds on Total Cholesterol, Total Protein, and Nitric Oxide
Al-Achi A Concise Treatise on Natural Remedies
RU2144371C1 (en) Homeopathic drug for treatment of patients with parasitic cholecystitis
FR2709964A1 (en) Antiviral pharmaceutical compositions proposed in the treatment of AIDS and herpes
EP1338303B1 (en) Detoxifying phytotherapeutic composition from two plant extracts and process for preparing the same
RU2144372C1 (en) Homeopathic drug for treatment of patient with parasitic cholecystitis caused by pathogen opistorehis telineus
WO2014116093A1 (en) Product based on a natural preparation for treating anaemia

Legal Events

Date Code Title Description
ST Notification of lapse